| RS2496866040 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496867576 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496867841 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2496867892 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496867941 |
RELA
|
Health Risk |
Likely pathogenic |
RELA-related disorder, RELA-related disorder |
| RS2496868089 |
SORL1
|
Health Risk |
Pathogenic |
— |
| RS2496868859 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496869455 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2496870461 |
CD3D
|
Health Risk |
Likely pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS2496871237 |
RELA
|
Health Risk |
Likely pathogenic |
— |
| RS2496871652 |
SORL1
|
Health Risk |
Likely pathogenic |
— |
| RS2496871974 |
MXI1
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |
| RS2496872144 |
CD3D
|
Health Risk |
Pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS2496872707 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2496872976 |
CD3D
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS2496875947 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496878023 |
CD3D
|
Health Risk |
Pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS2496878055 |
CD3D
|
Health Risk |
Pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS2496881754 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496881778 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
— |
| RS2496881864 |
TECTA
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2496881880 |
TECTA
|
Health Risk |
Likely pathogenic |
TECTA-related disorder, TECTA-related disorder |
| RS2496884365 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2496884567 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2496885188 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2496886120 |
ALG8
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2496886375 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2496887153 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496887510 |
MYO7A
|
Health Risk |
Likely pathogenic |
— |
| RS2496887636 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496887731 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2496888313 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2496889084 |
ALG8
|
Health Risk |
Pathogenic |
ALG8 congenital disorder of glycosylation, ALG8 congenital disorder of glycosylation |
| RS2496890055 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496890418 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2496890590 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2496891224 |
LRP5
|
Health Risk |
Likely pathogenic |
— |
| RS2496891596 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS2496893600 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496894090 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2496894498 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496894921 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496895658 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2496896737 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2496896960 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496897244 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2496897477 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496897586 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496897668 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2496898064 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496899267 |
LRP5
|
Health Risk |
Likely pathogenic |
— |
| RS2496899629 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2496901413 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS2496903018 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496903151 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496903379 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496903775 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496906689 |
TECTA
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2496908575 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS2496909463 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS2496909556 |
SORL1
|
Health Risk |
Pathogenic |
— |
| RS2496909934 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496910348 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496913119 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496913133 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496916736 |
TECTA
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12 |
| RS2496917677 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS2496917978 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496918077 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496918143 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Familial cancer of breast |
| RS2496918299 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496918509 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496918558 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496918604 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496918758 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496918974 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2496919120 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2496919200 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496919260 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496919542 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496919689 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496920213 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2496920427 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496921652 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2496921987 |
TECTA
|
Health Risk |
Likely pathogenic |
— |
| RS2496922131 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496922271 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496922607 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496922930 |
DYNC2H1
|
Health Risk |
Pathogenic |
DYNC2H1-related disorder, DYNC2H1-related disorder |
| RS2496922933 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2496924515 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2496924562 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2496924580 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2496925088 |
TECTA
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal recessive nonsyndromic hearing loss 21 |
| RS2496926041 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS2496929678 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2496929792 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2496930073 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2496930134 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Familial hyperinsulinism |
| RS2496930367 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |